Speaker
Vice President - Global Program & Oncology Lead, Bristol Myers Squibb
Giorgia Vicentini, Vice President - Global Program & Oncology Lead at Bristol Myers Squibb, spoke at 17th World ADC San Diego (San Diego, United States of America, 12–15 Oct 2026) in the session “Spotlighting the Clinical Performance of Izalontamab Brengitecan Bispecific ADC”.
12–15 Oct 2026San Diego, United States of America
Chief Scientific Officer, Iksuda Therapeutics
Associate Director, Medicinal Chemistry, AstraZeneca
Senior Director, Chemistry, Sutro Biopharma
Chief Scientific Officer, Callio Therapeutics
President & Founder, Bramhill Biologics Consulting
Executive Director, Product Stewardship Lead, AstraZeneca
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Giorgia Vicentini, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].